Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-035212
Filing Date
2020-12-28
Accepted
2020-12-28 16:55:09
Documents
1
Period of Report
2020-12-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4176
  Complete submission text file 0000899243-20-035212.txt   5515
Mailing Address C/O MIRNA THERAPEUTICS, INC. 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address
DeYoung Casi (Reporting) CIK: 0001652066 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39593 | Film No.: 201418951

Mailing Address 1018 W. 11TH STREET AUSTIN TX 78703
Business Address 1018 W. 11TH STREET AUSTIN TX 78703 919-864-2700
Shattuck Labs, Inc. (Issuer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations